OTCMKTS:GNGBY

Getinge Q3 2025 Earnings Results & Report

Getinge logo
$26.88 -0.39 (-1.44%)
As of 11/20/2026 03:58 PM Eastern

Getinge reported Q3 2025 earnings on October 21, 2025. The company reported EPS of $0.25, while revenue was $864.74 million.

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

Getinge EPS Results

Actual EPS
$0.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge Revenue Results

Actual Revenue
$864.74 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Getinge's next earnings date is estimated for Tuesday, January 26, 2027, based on past reporting schedules.

Conference Call Resources

Getinge Q3 2025 Earnings FAQ

Getinge (OTCMKTS:GNGBY) reported earnings of $0.25 per share for Q3 2025. The report was announced on Tuesday, October 21, 2025.

Getinge reported revenue of $864.74 million for Q3 2025.

Getinge's next earnings date is estimated for Tuesday, January 26, 2027. MarketBeat tracks confirmed and estimated earnings dates for Getinge on the company's earnings history page.

Getinge Earnings Headlines

Getinge Establishes Sustainable Financing Framework
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
Getinge AB Earnings Call Signals Steady Margin Climb
See More Getinge Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge and other key companies, straight to your email.

About Getinge

Getinge (OTCMKTS:GNGBY) is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products.

The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing.

Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.

View Getinge Profile